Letter

Angiotensin receptor blockers and myocardial infarction

BMJ 2005; 330 doi: 10.1136/bmj.330.7502.1270-a (Published 26 May 2005)
Cite this as: BMJ 2005;330:1270.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Cautions voiced are biologically credible

  1. Zaheer R Yousef, specialist registrar (zypusef@dircon.co.uk),
  2. Francisco Leyva, consultant cardiologist,
  3. Christopher Gibbs, consultant cardiologist
  1. Department of Cardiology, Good Hope Hospital, Sutton Coldfield, West Midlands B75 7RR

    Editor—We agree with Verma and Strauss that it is naive to consider that angiotensin receptor blockers are like angiotensin converting enzyme (ACE) inhibitors, but without the cough.1 Although the evidence is conflicting, the hypothesis that angiotensin receptor blockers may predispose to myocardial infarction when used in preference to ACE inhibitors warrants further attention.

    Long term clinical benefits of …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular